Testing extra brain scans to read changes after glioblastoma treatment
Original title: Identifying Findings on Brain Scans That Could Help Make Better Predictions About Brain Cancer Progression, The GABLE Trial
How far along is this research?
This is a trial that is enrolling or has been updated. It is not a finding yet.
This is a middle stage test in people, not something your own doctor can offer yet.
Status: Recruiting. It is looking for patients now. Talk to your care team about whether it fits you.
The trial team last updated this record on . Always check the trial page for the latest.
The short version
This study tests if extra scans can tell tumor growth apart from treatment effects.
Who this trial is for. This trial is for people who were just diagnosed with glioblastoma: The fastest-growing type of glioma (grade 4). Treatment usually starts soon after diagnosis: surgery first, then radiation and chemotherapy. See the glossary, a brain cancer. It tests other kinds of scans, like DSC-MRI, PET, and MR spectroscopy, next to the usual MRI.
Where it stands. This trial has not reported results. It is measuring how well these scans show what a tumor is doing. Doctors want to know if a change on a scan is the tumor growing or the treatment at work. The answer is not in yet.
What this means, and what it doesn't
What it could mean: Right now this changes nothing about your care. If it works, scans may one day give doctors a clearer read after treatment. Someone who fits this trial could ask their care team about it.
What it doesn't mean: This does not mean these scans are proven. A trial is a test, not a treatment you can count on. Joining a trial is not a promise that it will help you. It is not a cure, and it is not a promise of one.
Source: ClinicalTrials.gov, August 13, 2026 · Read the original
This plain-language summary was written by AI and published automatically after passing our automatic safety checks. How we write.